Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
AFC to Invest $3.3 Million in Continuous Processing
1:35 PM MDT | October 22, 2007 | Michelle Bryner
Ampac Fine Chemicals (AFC) is expanding its technology portfolio to include continuous processing for active pharmaceutical ingredient (API) production, the company told CW at the CPhI pharmaceutical manufacturing expo, held in Milan earlier this month (CW, Oct. 10/17, p. 37). The company says it will invest approximately $3.3 million in fiscal 2008 to develop this technology. Malik: Changing from batch to continuous. Continuous processing is not widely used in the pharma industry for several reasons, including the “misconception” that continuous...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee